Literature DB >> 3851696

Tumour necrosis factor and the lysosomal enzymes of macrophages or macrophage-like cell line.

A Sakurai, N Satomi, K Haranaka.   

Abstract

The relationship between tumour necrosis factor (TNF) and macrophages or macrophage-like cell line, especially the lysosomal enzymes was investigated. The serum lysosomal enzymes and LDH activities were increased in proportion to the TNF production even in different strains of mice. Lysosomal enzymes and TNF activity were released into the supernatant of the culture medium of macrophage-enriched peritoneal exudate cells (PEC) or spleen cells derived from Propionibacterium acnes-primed mice after addition of lipopolysaccharide (LPS). After passage through a Sephadex G-10 column, TNF activity could not be detected in the supernatant of these spleen cells after addition of LPS. Also TNF activity could not be detected in the supernatant following destruction of PEC. These results suggest that TNF producibility is strongly related to the degree of activation of macrophages, especially the lysosomal enzymes. The murine macrophage-like cell line, J774, also released TNF activity and lysosomal enzymes after addition of LPS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3851696     DOI: 10.1007/bf00199766

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  16 in total

1.  Effect of tumour necrosis factor on cultured human melanoma cells.

Authors:  L Helson; S Green; E Carswell; L J Old
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

2.  Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine.

Authors:  P R KIND; E J KING
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

3.  Tumor necrosis factor.

Authors:  L J Old
Journal:  Clin Bull       Date:  1976

4.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

5.  Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice.

Authors:  K Haranaka; N Satomi; A Sakurai
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

6.  Research on the production site of tumor necrosis factor (TNF).

Authors:  N Satomi; K Haranaka; O Kunii
Journal:  Jpn J Exp Med       Date:  1981-12

7.  Effects of murine tumor necrosis factor on heterotransplanted human tumors.

Authors:  L Helson; C Helson; S Green
Journal:  Exp Cell Biol       Date:  1979

8.  Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages.

Authors:  J Schnyder; M Baggiolini
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties.

Authors:  N Matthews; J F Watkins
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

10.  Differences in tumour necrosis factor productive ability among rodents.

Authors:  K Haranaka; N Satomi; A Sakurai
Journal:  Br J Cancer       Date:  1984-10       Impact factor: 7.640

View more
  3 in total

1.  Augmentation of the human monocyte/macrophage chemiluminescence response during short-term exposure to interferon-gamma and tumour necrosis factor-alpha.

Authors:  L M Kumaratilake; A Ferrante; E J Bates; I C Kowanko
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

2.  Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts.

Authors:  S Onodera; K Suzuki; T Matsuno; K Kaneda; T Kuriyama; J Nishihira
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

3.  The interaction of the macrophage and the osteoblast in the pathophysiology of aseptic loosening of joint replacements.

Authors:  S M Horowitz; B P Rapuano; J M Lane; A H Burstein
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.